The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.
Recent Posts
- Here’s a way to graduate from college with little to no student debt
- Jeffrey Gundlach sees one of the ‘least healthy’ stock markets of his career, urges 20% cash
- Standard Medicare Part B monthly premium to jump 9.7% in 2026
- Nvidia CEO Jensen Huang surprised investors with a ‘half a trillion’ forecast. It’ll come up at earnings
- Alphabet rallies after Berkshire reveals stake. Why Buffett’s firm likely bought it